-
Mashup Score: 5Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial - 1 year(s) ago
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used for circulatory support in cardiogenic shock patients, although the evidence supporting its use in t
Source: CirculationCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0VIDEO: ACC president shares his key takeaways from ACC 2022 - 2 year(s) ago
“It was just what the doctor ordered,” Fry said of the return to a normal, in-person format after two years of virtual meetings due to the pandemic. “It was a real shot in the arm for people who were striving for that real person-to-person contact and communications, which obviously is not replicable over video.” Fry said there were several…
Source: Cardiovascular BusinessCategories: Cardiology News and Journals, Latest HeadlinesTweet-
VIDEO: ACC president shares his key takeaways from ACC 2022 Watch Here: https://t.co/U4keCzUUkc #Cardiology #ACC #ACC22 #ACC2022 #cardiotwitter
-
-
Mashup Score: 0FAME 3 subanalysis adds twist to negative primary results - 2 year(s) ago
A quality of life subanalysis suggests PCI with fractional flow reserve might be preferred over CABG by at least some patients.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
FAME 3 subanalysis adds twist to negative primary results. https://t.co/odBPmksXWh #ACC2022 https://t.co/IwOHGJ3cBX
-
-
Mashup Score: 0Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival - 2 year(s) ago
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class alone.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
Combination of SGLT2 inhibitor + GLP-1RA boosts diabetes survival. https://t.co/aXHMdlyGH0 #ACC2022 https://t.co/4cE9gKFHMT
-
-
Mashup Score: 0New smart device shows highly accurate AFib detection: mAFA II - 2 year(s) ago
The study, conducted in a mass low-risk population in China, correctly identified atrial fibrillation in more than 93% of suspected cases detected.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
New smart device shows highly accurate AFib detection: mATA II. https://t.co/awxZImWU87 #ACC2022
-
-
Mashup Score: 0Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients - 2 year(s) ago
Empagliflozin showed symptomatic benefits in patients hospitalized for acute heart failure after 2 weeks in a secondary analysis from the EMPULSE trial.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Empagliflozin rapidly improves acute heart failure symptoms in hospitalized patients. https://t.co/DQouwi7YU4 #ACC2022 https://t.co/rcjRhx35Nt
-
-
Mashup Score: 3Combo of SGLT2 inhibitor + GLP-1 RA boosts diabetes survival - 2 year(s) ago
Survival of patients with type 2 diabetes and CVD rose by 80% when they received both an SGLT2 inhibitor and GLP-1 RA, compared with either class alone.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Combination of SGLT2 inhibitor + GLP-1RA boosts #diabetes survival. https://t.co/w7lfnDawcX #ACC2022 https://t.co/rt1fD6Ncvc
-
-
Mashup Score: 14Aspirin exposure fails to reduce cardiovascular event risk - 2 year(s) ago
Post hoc analysis showed no additional benefit from aspirin in reducing cardiovascular risk for hypertension patients with controlled systolic blood pressure.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The addition of aspirin to standard guideline management for BP did not reduce the risk of cardiovascular events among adults with #hypertension and controlled systolic blood pressure. https://t.co/UxK1soSP7B #ACC2022 https://t.co/0XUhabjWYj
-
-
Mashup Score: 0New smart device shows highly accurate AFib detection: mAFA II - 2 year(s) ago
The study, conducted in a mass low-risk population in China, correctly identified atrial fibrillation in more than 93% of suspected cases detected.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
New smart device shows highly accurate AFib detection: #mATA II. https://t.co/GH6yEpA5qs #ACC2022
-
-
Mashup Score: 1Aspirin exposure fails to reduce cardiovascular event risk - 2 year(s) ago
Post hoc analysis showed no additional benefit from aspirin in reducing cardiovascular risk for hypertension patients with controlled systolic blood pressure.
Source: www.mdedge.comCategories: General Medicine News, Latest HeadlinesTweet-
The addition of aspirin to standard guideline management for BP did not reduce the risk of cardiovascular events among adults with hypertension and controlled systolic blood pressure. https://t.co/3Di2jyp0XX #ACC2022 https://t.co/lthXrLJRt3
-
RT @Auribarri: 🔥#ACC2022 ECMO-CS. Tras leer el manuscrito en https://t.co/IE5vXfOU7N es importante aclarar: - No se compara si el #ECMO es…